TP20 - Transcranial Magnetic Stimulation for Treatment-resistant Depression
Tuesday, May 6, 2025
12:30 PM – 1:00 PM ET
Location: Hall BCD
This session will explore the successful implementation of a Transcranial Magnetic Stimulation (TMS) program at a Certified Community Behavioral Health Organization (CCBHO) in Missouri, highlighting its effectiveness in treating patients with treatment-resistant depression. Attendees will learn about the program's structure, including patient outcomes, with 66% of participants achieving significant symptom reduction. The presentation will address both the challenges and successes of integrating TMS into a community healthcare setting, alongside an analysis of patient experiences and long-term follow-up data. Attendees will gain insights into the practical application of TMS, its potential for mood improvement, and areas for further research and optimization.
Learning Objectives:
Describe the TMS approach for treating TRD, including the necessary equipment, the underlying mechanisms of action, and the challenges and facilitators encountered in implementing TMS in a community setting.
Discuss the implementation process of a TMS program in a CCBHO, focusing on staff training, patient selection, and treatment protocols.
Evaluate the preliminary outcomes of the TMS program, particularly in relation to response rates, patient satisfaction, and symptom reduction in individuals with treatment-resistant depression.
